Scarica l'app Stockscreener
4.29
3.16%
-0.14
Dopo l'orario di chiusura:
4.05
-0.24
-5.59%
Precedente Chiudi:
$4.43
Aprire:
$4.2
Volume 24 ore:
144.49K
Relative Volume:
16.59
Capitalizzazione di mercato:
$5.54M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.18
$4.45
Intervallo di 1 settimana:
$4.0001
$5.00
Portata 52W:
$4.0001
$5.00
Applied Dna Sciences Inc Stock (BNBX) Company Profile
Nome
Applied Dna Sciences Inc
Settore
Industria
Telefono
631-240-8800
Indirizzo
50 HEALTH SCIENCES DRIVE, STONY BROOK
Confronta BNBX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNBX
Applied Dna Sciences Inc
|
4.29 | 5.72M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Applied Dna Sciences Inc Stock (BNBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-02-12 | Iniziato | ROTH Capital | Buy |
| 2021-01-14 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-18 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-20 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-02 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-14 | Reiterato | Maxim Group | Buy |
| 2016-05-13 | Reiterato | Maxim Group | Buy |
| 2015-10-08 | Reiterato | Maxim Group | Buy |
| 2015-05-26 | Iniziato | The Benchmark Company | Speculative Buy |
| 2015-02-10 | Reiterato | Maxim Group | Buy |
| 2015-01-13 | Iniziato | Maxim Group | Buy |
Mostra tutto
Applied Dna Sciences Inc Borsa (BNBX) Ultime notizie
Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences - New Jersey Herald
Intraday pattern recognizer results for Applied DNA Sciences Inc.July 2025 Fed Impact & High Accuracy Investment Signals - newser.com
What’s next for Applied DNA Sciences Inc. stock priceWeekly Stock Summary & Weekly High Potential Alerts - newser.com
What MACD signals say about Applied DNA Sciences Inc.Portfolio Growth Summary & Long-Term Investment Growth Plans - newser.com
Applied DNA Sciences Announces New CEO Appointment - MSN
Applied DNA Sciences, Inc. will Change its Ticker to BNBX from APDN - MarketScreener
Applied DNA says on Sept 30 co implemented restructuring planSEC filing - MarketScreener
Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy - PharmiWeb.com
Applied DNA Sciences to Update Ticker Symbol to BNBX - GuruFocus
Applied DNA Sciences to change ticker symbol to BNBX - Investing.com
Applied DNA Sciences to change ticker symbol to BNBX By Investing.com - Investing.com South Africa
Applied DNA Sciences changes ticker to BNBX reflecting digital asset focus - Investing.com Nigeria
What analysts say about Applied DNA Sciences Inc stockPrice Gap Trading Strategies & Rapid Profit Growth - earlytimes.in
Applied DNA Sciences Announces Private Placement Offering - TipRanks
Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga
What drives Applied DNA Sciences Inc stock priceCandlestick Pattern Analysis & Minimize Portfolio Damage with Warnings - earlytimes.in
Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation - 01net
Applied DNA Launches $58 Million Private Placement in Pivot to Crypto Treasury - MarketScreener
Applied DNA Sciences secures up to $58 million for BNB treasury strategy - Investing.com
Applied DNA Sciences Inc announces private placement of up to $58 mln - MarketScreener
Applied DNA Sciences Inc Announces Private Placement Of Up To $58 Mln - TradingView
Full technical analysis of Applied DNA Sciences Inc. stockEarnings Performance Report & Weekly Setup with High ROI Potential - newser.com
Applied DNA Sciences, Inc. announced that it expects to receive $26.8 million in funding - MarketScreener
Applied DNA to present nucleic acid solutions at Boston conferences By Investing.com - Investing.com Canada
Breakthrough DNA Platform for mRNA and CAR-T: Applied DNA Presents at Two Major Industry Conferences - Stock Titan
BPAS - FinancialContent
Long Island gains two new women CEOs; gender gap persists - Newsday
Applied DNA Reports Third Quarter Fiscal 2025 Financial Results - Fall River Herald News
Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application - ACCESS Newswire
Applied DNA Lands 7th Major Order as Global Cancer Diagnostic Maker Expands LineaDNA Usage - Stock Titan
Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements - FinancialContent
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Applied DNA Sciences Announces Strategic Restructuring - TipRanks
Dr. James A. Hayward Retires from Applied DNA Sciences - Dentistry Today
Applied DNA Sciences names Judy Murrah as new chairperson and CEO - Investing.com
Applied DNA Sciences Returns to Regular Earnings Updates: What Investors Should Know About New Schedule - Stock Titan
applied dna sciences faces nasdaq delisting due to bid price rule - Investing.com UK
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - The Holland Sentinel
APDN stock plunges to 52-week low of $0.32 amid market challenges - Investing.com Canada
Applied DNA Sets Reverse Stock Split for June 2, Moves Key Investor Call to June 17 - Stock Titan
APDN stock plunges to 52-week low of $0.62 amid market challenges - Investing.com
Applied DNA Sciences Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results - ACCESS Newswire
Applied DNA Announces Double Update: Q2 Earnings Plus Special Strategic Priorities Discussion - Stock Titan
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA - FinancialContent
Applied DNA Overcomes Delisting Threat: Successfully Maintains Nasdaq Standards - Stock Titan
APDN stock plunges to 52-week low at $1.14 amid steep decline - Investing.com
Growth or Bubble? APDN’s Unexpected Surge - timothysykes.com
APDN Stock Plummets: Opportunity or Warning? - timothysykes.com
Applied DNA Sciences Announces Major Share Consolidation to Maintain Nasdaq Listing - Stock Titan
Applied DNA abandons DNA authentication business - Anti-counterfeiting news
Applied Dna Sciences Inc Azioni (BNBX) Dati Finanziari
Non sono disponibili dati finanziari per Applied Dna Sciences Inc (BNBX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.17%
2.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):